Top Heart Programs Choose Safety of Medivance’s Non-Invasive Arctic Sun(R) for Therapeutic Hypothermia
Best hospitals adhere to trend in medicine favoring non-invasive interventions that minimize needless complications
Cooling comatose cardiac arrest survivors is an evidence-based standard of care recommended by the American Heart Association.
“Therapeutic hypothermia is the single most effective intervention to improve neurologic outcome after out-of-hospital cardiac arrest,” says Brian O’Neil, MD, Emergency Department Research Director at Beaumont Hospital in
The preference for the Arctic Sun is in keeping with the strong trend in medicine toward least invasive methods. Consequently, more than half of the 50 heart programs ranked best in the nation by U.S. News & World Report now use the Arctic Sun to quickly induce hypothermia and then slowly rewarm their critically ill patients. In the topmost ranks, 80 percent of the 20 top hospitals prefer the safety and precision of Medivance’s non-invasive device.
“We use the Arctic Sun for two reasons. It’s non-invasive, and it’s extremely reliable for maintaining temperature within the narrow range required for maximum therapeutic benefit,” Dr. O’Neil says.
The non-invasive Arctic Sun System avoids the unnecessary risks associated with invasive cooling catheters. And because nurses initiate the therapy, cooling begins quickly when minutes count.
Arctic Sun users ranked among best heart programs, move up in rankings
Six hospitals that use the Arctic Sun were added to the U.S. News & World Report list of best 50 heart programs, and five others saw their rankings rise in the past two years.
“That the majority of the nation’s best-rated heart hospitals prefer the safety, ease of use and efficiency of the Arctic Sun clearly substantiates the Arctic Sun’s market leadership,” says Medivance CEO
About Medivance’s Arctic Sun
The non-invasive Arctic Sun Temperature Management System precisely monitors and maintains core body temperature in a therapeutic range, between 32 degrees and 38.5 degrees Celsius (approximately 89.6 degrees to 101.3 degrees Fahrenheit) with the potential to minimize damage to the heart and brain. The patented design of the Arctic Sun and ArcticGel(TM) Pads enables them to transfer up to five times more thermal energy than conventional products such as water blankets, wraps or ice packs, resulting in more efficient temperature management. The system’s precision also enables the slow rewarming thought to be critical to therapeutic benefit. The Arctic Sun has received 510(k) FDA clearance in the U.S., the European Union’s CE Mark, marketing approval in
Photos available for download at http://www.medivance.com/html/Media/medLibrary.html